Representative cases from both ER+HER2– and TNBC subtypes, illustrating the extracted Ki67-ITH and CD8-immunogradient indicators in pdf format.

<p>Representative cases from both ER+HER2– and TNBC subtypes, illustrating the extracted Ki67-ITH and CD8-immunogradient indicators in pdf format.</p>

Publication Details

Journal
Figshare
Published
2024-11-22
DOI
https://doi.org/10.1371/journal.pone.0314364.s002
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Representative cases from both ER+HER2– and TNBC subtypes, illustrating the extracted Ki67-ITH and CD8-immunogradient indicators in pdf format.

Figshare
HER2/EGFR in Cancer Research
article

Representative cases from both ER+HER2– and TNBC subtypes, illustrating the extracted Ki67-ITH and CD8-immunogradient indicators in pdf format.

article en

Abstract

<p>Representative cases from both ER+HER2– and TNBC subtypes, illustrating the extracted Ki67-ITH and CD8-immunogradient indicators in pdf format.</p>

Figshare
Openalex Percentile: Top 54%
HER2/EGFR in Cancer Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Representative cases from both ER+HER2– and TNBC subtypes, illustrating the extracted Ki67-ITH and CD8-immunogradient indicators in pdf format. · Figshare (2024) | TGRS Research Map | TGRS